A carregar...
ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan
Irinotecan is a key drug for patients with advanced and recurrent colorectal carcinoma. However, the efficacy of irinotecan is not sufficient; partly, as there is no useful marker to predict chemosensitivity to the drug. The aim of the present study was to evaluate whether the expression levels of a...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038226/ https://ncbi.nlm.nih.gov/pubmed/27698852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4937 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|